Abstract:FGF2; fibroblast growth factor 2; FGFR, fibroblast growth factor receptor; ITGA2, integrin alpha 2; PI3K, phosphoinositide 3‐kinase; AKT, protein kinase B; Oct4, octamer‐binding transcription factor 4; Nanog, Nanog homeobox; Sox2, sex determining region Y‐box 2. Bone marrow‐derived mesenchymal stem cells (BMSC) are promising cellular reservoirs for treating degenerative diseases, tissue injuries, and immune system disorders. However, the stemness of BMSCs tends to decrease during in vitro cultivation, thereby restricting their efficacy in clinical applications. Consequently, investigating strategies that bolster the preservation of BMSC stemness and maximize therapeutic potential is necessary. Transcriptomic and single‐cell sequencing methodologies were used to perform a comprehensive examination of BMSCs with the objective of substantiating the pivotal involvement of fibroblast growth factor 2 (FGF2) and integrin alpha 2 (ITGA2) in stemness regulation. To investigate the impact of these genes on the BMSC stemness in vitro, experimental approaches involving loss and gain of function were implemented. These approaches encompassed the modulation of FGF2 and ITGA2 expression levels via small interfering RNA and overexpression plasmids. Furthermore, we examined their influence on the proliferation and differentiation capacities of BMSCs, along with the expression of stemness markers, including octamer‐binding transcription factor 4, Nanog homeobox, and sex determining region Y‐box 2. Transcriptomic analyzes successfully identified FGF2 and ITGA2 as pivotal genes responsible for regulating the stemness of BMSCs. Subsequent single‐cell sequencing revealed that elevated FGF2 and ITGA2 expression levels within specific stem cell subpopulations are closely associated with stemness maintenance. Moreover, additional in vitro experiments have convincingly demonstrated that FGF2 effectively enhances the BMSC stemness by upregulating ITGA2 expression, a process mediated by the phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway. This conclusion was supported by the observed upregulation of stemness markers following the induction of FGF2 and ITGA2. Moreover, administration of the BEZ235 pathway inhibitor resulted in the repression of stemness transcription factors, suggesting the substantial involvement of the PI3K/AKT pathway in stemness preservation facilitated by FGF2 and ITGA2. This study elucidates the involvement of FGF2 in augmenting BMSC stemness by modulating ITGA2 and activating the PI3K/AKT pathway. These findings offer valuable contributions to stem cell biology and emphasize the potential of manipulating FGF2 and ITGA2 to optimize BMSCs for therapeutic purposes.

FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency

FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling

KLF2 Regulates Stemness of Human Mesenchymal Stem Cells by Targeting FGFR3

TGF-β Signaling in Stem Cell Regulation.

Regulation of embryonic stem cell self-renewal and differentiation by TGF-β family signaling

TGFβ Family Signaling in Human Stem Cell Self-Renewal and Differentiation

Promoting Reprogramming by Fgf2 Reveals That the Extracellular Matrix is A Barrier for Reprogramming Fibroblasts to Pluripotency

Dissecting Signaling Pathways That Govern Self-renewal of Rabbit Embryonic Stem Cells

Inhibition of Transforming Growth Factor Β (Tgf-Β) Signaling Can Substitute for Oct4 Protein in Reprogramming and Maintain Pluripotency*

Signaling networks in the control of pluripotency

The extracellular signal-regulated kinase signaling pathway in biology of pluripotent stem cells

Folic Acid Supports Pluripotency and Reprogramming by Regulating LIF/STAT3 and MAPK/ERK Signaling.

Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells

Fibroblast growth factor 2 enhances BMSC stemness through ITGA2‐dependent PI3K/AKT pathway activation

Pluripotency Factors on Their Lineage Move

Pluripotency Crossroads: Junction of Transcription Factors, Epigenetic Mechanisms, MicroRNAs, and Long Non-coding RNAs.

Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells.

Cooperation of FGF/MEK/ERK and Wnt/β-catenin Pathway Regulators to Promote the Proliferation and Pluripotency of Mouse Embryonic Stem Cells in Serum- and Feeder-Free Conditions

A FGF2-mediated Incoherent Feedforward Loop Induces Erk Inhibition and Promotes Naïve Pluripotency

Fibroblast Growth Factor Regulates Human Neuroectoderm Specification Through ERK1/2-PARP-1 Pathway

GPR160 Regulates the Self-Renewal and Pluripotency of Mouse Embryonic Stem Cells Via JAK1/STAT3 Signal Pathway